Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization [PDF]
Neil M. Bressler +9 more
openalex +1 more source
Real-World Outcomes of Antiangiogenic Therapy in Patients With Wet Age-Related Macular Degeneration. [PDF]
Solano Pineda DL +8 more
europepmc +1 more source
One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration [PDF]
Supriya Arora, Martin McKibbin
openalex +1 more source
Modeling the Ocular Pharmacokinetics and Pharmacodynamics of Ranibizumab for Improved Understanding and Data Collection Strategies in Ocular Diseases. [PDF]
Crawshaw JR +4 more
europepmc +1 more source
Quantitative Assessment of En‑face OCT‑Derived Minimum Intensity Fluid Changes Following Ranibizumab Biosimilar Therapy in Macular Neovascularization Secondary to nAMD and PCV. [PDF]
Sheth JU +3 more
europepmc +1 more source
Updates in the treatment of neovascular glaucoma: From conventional approaches to novel therapies. [PDF]
Verma S, Midha N, Udenia H, Dada T.
europepmc +1 more source

